Participate in the ELIXIR Innovation and SME Forum at [BC]2 to learn about solutions for preventive medicine and the whole learning ecosystem of health. Thanks to the support by ELIXIR, the intergovernmental organisation that brings together life science resources from across Europe, participation at the ELIXIR Forum is free of charge.

REGISTER NOW

The learning ecosystem of health

From treatment to prevention: challenges in data management and analysis
Biomedical research has traditionally focused on disease diagnosis and treatment. With the recent surge of data from healthy citizens or from patients in the post-treatment phase, the new horizon in healthcare lies in better detecting signs of disease onset or in avoiding long-term relapses with the ultimate goal of preventing both.

[BC]2 will host a one-day ELIXIR Innovation and SME Forum entitled “Building the learning ecosystem of health: from data tracking to preventive medicine” on 13 September. The aim of the day is to foster knowledge sharing and collaborations between academia and industry around the technologies, data science and learnings’ implementation associated with preventive medicine and treatment follow-up.


The Programme Committee has put together a diverse schedule with talks from high-profile speakers, interactive panel discussions, and selected talks from across the biomedical research and healthcare ecosystem. The aim of the day will be to explore solutions to better understand the different components of the learning ecosystem of health and preventive medicine, from technologies to track data and data management, to data integration, analysis and translation into preventive guidelines and healthcare measures.

Our keynote speakers

Serena Scollen

ELIXIR, UK
Twitter

After her PhD at the University of Cambridge (UK), Serena Scollen performed her postdoctoral training at University of Cambridge (UK) and the Imperial College in London (UK). From 2010 to 2016, she has been Head of Genetics at Pfizer. In 2016, she became Head of the Human Genomics and Translational Data section of ELIXIR.

As part of her responsibilities in this position, she coordinates the Beyond 1 Million Genomes (B1MG) project, an initiative of 23 European countries aiming to create a network of genetic and clinical data across Europe. Access to people’s genetic and clinical data is key in personalising medicine, helping clinicians to detect diseases earlier, predict their development and to decide on the best possible treatments.



Bogi Eliasen

Copenhagen Institute for Future Studies, Denmark
Twitter

Bogi Eliasen holds a Master Degree in Political Science and International Law from the University of Aarhus (Denmark). He has worked as a consultant for politicians, the public sector and private companies and is co-founder and manager of the FarGen - Faroe Genome Project –  a national project planning on sequencing the genome of all the Faroese people with the aim to develop a platform for genetic research of the Faroese population.

Since 2020, Bogi Eliasen is Director of Health at the Copenhagen Institute for Future Studies. At the ELIXIR Forum, he will present and discuss several ideas and visions on how health systems have to change and adapt to the increasing  amount of available data in the future.

Schedule and selected presentations

Schedule

Time Activity
08:30 – 09:00 Registration
09:00 – 09:30 Introduction to SIB, ELIXIR and the ELIXIR Innovation and SME Forum
09:30 – 10:15 Keynote presentation – Serena Scollen
10:15 – 10:45  Coffee break
10:45 – 12:15 Selected abstracts
  • Curation and integration of single-cell RNA-Seq data for cross-study analysis and interpretation (Nebion AG)
  • Hematocrit self-testing for Polycytaemia vera patients at home - A collaboration of physicians, device manufacturer Nova Biomedical and Novartis (Novartis)
  • Integrating relevant phenotype and genomic data in EHR with SNOMED CT, LOINC and other Genomic Standards (BITAC)
  • NFL/NBA 2020-2021 Sports Season COVID-19 Monitoring (IQVIA) 
12:15 – 13:15 Lunch break
13:15 – 14:45 Selected abstracts
  • Pill Protect: an innovative and integrated tool for the benefit of patients (Gene Predictis)
  • Bringing the world’s health knowledge to research and medical decision makers. (HealthECCO)
  • MyPharmaGenes: Pharmacogenetics in clinical practice (HeartGenetics)
14:45 – 15:05 Invited talk
15:05 – 15:50 Keynote presentation – Bogi Eliasen
15:50 – 16:40 Panel discussion and conclusion
17:00 [BC]2 Welcome lecture


Connecting the different layers and components of the learning ecosystem of health is one of the key challenges toward preventive medicine. Several start-ups and SMEs have been selected to present their solutions to overcome this challenge.

  • Integrating relevant phenotype and genomic data in EHR with SNOMED CT, LOINC and other Genomic Standards
    BITAC, Spain
    #Health data tracking   #Data integration   #Data management

  • Pill Protect: an innovative and integrated tool for the benefit of patients
    Gene Predictis, Switzerland
    #Diagnosis   #Data analysis   #Medical prevention

  • Bringing the world’s health knowledge to research and medical decision makers.
    HealthECCO, Germany
    #Data integration   #Data analysis   #Guidelines development

  • MyPharmaGenes: Pharmacogenetics in clinical practice
    HeartGenetics, Genetics and Biotechnology SA, Portugal
    #Data integration   #Translation to healthcare   #Medical prevention

  • NFL/NBA 2020-2021 Sports Season COVID-19 Monitoring 

    IQVIA, United Kingdom
    #Prevention   #Diagnosis   #Treatment

  • Curation and integration of single-cell RNA-Seq data for cross-study analysis and interpretation
    Nebion AG, Switzerland
    #Diagnosis   #Data analysis   #Medical prevention

  • Hematocrit self-testing for Polycytaemia vera patients at home - A collaboration of physicians, device manufacturer Nova Biomedical and Novartis
    Novartis, Switzerland
    #Treatment follow-up   #Feedback on treatment   #Health data tracking

About ELIXIR and its Swiss node

ELIXIR unites Europe’s leading life science organizations in managing and safeguarding the increasing volume of data being generated by research. It coordinates, integrates and sustains bioinformatics resources across its member states and enables users in academia and industry to access services that are vital for their research.

In each country, so called ELIXIR Nodes run the resources and services that are part of ELIXIR. The Swiss node is coordinated by SIB. As part of its efforts to connect researchers from academia, industry and healthcare in Europe, SIB has decided to organise one of the ELIXIR Innovation and SME Forums at the 2021 of the [BC]2 Basel Computational Biology Conference.

As a provider of various renowned bioinformatics resources, expertise and teaching activities to the international life science community, SIB also interacts with ELIXIR at several levels:

  • Two of SIB’s supported bioinformatics resources are part of ELIXIR’s Core Data Resources: UniProtKB/Swiss-Prot and STRING (read more)
  • A study by SIB and supported by ELIXIR compared existing funding models towards sustainable funding of core data resources in the life sciences (Gabella C et al. F1000Research 2017, 6(ELIXIR):2051 - read more and watch the interview)
  • SIB co-led the development of the governance and processes supporting the identification and evaluation of ELIXIR Core Data Resources (Durinx C et al., F1000Research 2016, 5:2422)
  • SIB co-leads the ELIXIR Data and Training Platforms and is involved in several other work streams, such as the benchmarking of software tools